Insider Trading activities at Arcutis Biotherapeutics, Inc. (ARQT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arcutis Biotherapeutics, Inc. (ARQT) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arcutis Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1787306.

Total stock buying since 2020: $66,422,679.
Total stock sales since 2020: $41,324,555.
Total stock option exercises since 2020: $677,177.


 1   2 
20 insiders reported insider trading activities at Arcutis Biotherapeutics, Inc. (ARQT):
Insider trading activities of Curran Terrie
Insider trading activities of Topper James N
Insider trading activities of Heron Patrick J
Insider trading activities of Lock Kenneth A.
Insider trading activities of Chaudhuri Bhaskar
Insider trading activities of Turney Patricia A.
Insider trading activities of Silverstein Jonathan
Insider trading activities of Osborne David W
Insider trading activities of Smither John W
Insider trading activities of Vairavan Latha
Insider trading activities of Edwards Larry Todd
Insider trading activities of Schwartz Jeffrey Lawrence
Insider trading activities of Burrows Scott L
Insider trading activities of Welgus Howard G.
Insider trading activities of Burnett Patrick
Insider trading activities of Moore Matthew Richard
Insider trading activities of Orbimed Capital Gp Vii Llc
Insider trading activities of Matsuda Masaru
Insider trading activities of Watanabe Todd Franklin
Insider trading activities of Topper David Joseph

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Arcutis Biotherapeutics, Inc. (ARQT).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 13,734 $184,863 279,982 $4,026,204 66,000 $0
2024 27,802 $226,302 358,448 $3,340,439 84,114 $44,738
2023 81,463 $209,333 68,415 $978,355 93,525 $157,205
2022 0 $0 1,298,783 $27,133,327 32,847 $42,821
2021 0 $0 144,037 $4,184,117 95,610 $158,733
2020 3,403,893 $65,802,181 57,600 $1,662,113 137,003 $273,680

Table 2. Monthly summary of insider trading at Arcutis Biotherapeutics, Inc. (ARQT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 10,000 $156,380 10,000 $0
2025-08 0 $0 38,623 $558,179 10,000 $0
2025-07 0 $0 37,958 $560,139 28,750 $0
2025-06 4,914 $64,854 10,139 $135,578 0 $0
2025-05 8,820 $120,009 32,197 $472,094 0 $0
2025-04 0 $0 19,600 $302,939 0 $0
2025-03 0 $0 79,537 $1,181,311 17,250 $0
2025-02 0 $0 51,928 $659,584 0 $0
2024-12 0 $0 1,691 $23,674 0 $0
2024-11 2,750 $19,540 140,038 $1,371,235 34,500 $0
2024-10 0 $0 13,725 $129,914 0 $0
2024-09 0 $0 21,626 $217,960 0 $0
2024-08 0 $0 44,641 $409,827 6,614 $11,118
2024-07 0 $0 10,000 $93,140 10,000 $16,810
2024-06 0 $0 10,000 $80,070 10,000 $16,810
2024-05 4,000 $6,768 115,402 $1,009,928 23,000 $0
2024-03 21,052 $199,994 0 $0 0 $0
2024-01 0 $0 1,325 $4,691 0 $0
2023-12 0 $0 0 $0 59,525 $100,061
2023-11 0 $0 1,850 $3,661 0 $0
2023-10 80,000 $200,000 0 $0 0 $0
2023-08 0 $0 1,605 $11,307 0 $0
2023-05 1,463 $9,333 1,830 $14,277 0 $0
2023-04 0 $0 17,000 $220,813 17,000 $28,576

Table 3. Detailed insider trading at Arcutis Biotherapeutics, Inc. (ARQT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-02 Welgus Howard G. Sale 10,000 15.64 156,380
2025-09-02 Welgus Howard G. Option Ex 10,000 .00 0
2025-08-21 Burnett Patrick (See Remarks) Sale 2,438 15.57 37,969
2025-08-19 Burnett Patrick (See Remarks) Sale 1,750 16.16 28,280
2025-08-08 Burnett Patrick (See Remarks) Sale 3,847 14.03 53,988
2025-08-04 Vairavan Latha (SVP Chief Financial Officer) Sale 89 14.33 1,275
2025-08-04 Watanabe Todd (See Remarks) Sale 11,547 14.33 165,433
2025-08-04 Matsuda Masaru (See Remarks) Sale 6,330 14.33 90,689
2025-08-04 Burnett Patrick (See Remarks) Sale 2,622 14.33 37,565
2025-08-01 Welgus Howard G. Sale 10,000 14.30 142,980
2025-08-01 Welgus Howard G. Option Ex 10,000 .00 0
2025-07-14 Burnett Patrick (See Remarks) Sale 5,750 15.07 86,652
2025-07-14 Burnett Patrick (See Remarks) Option Ex 5,750 .00 0
2025-07-10 Burnett Patrick (See Remarks) Sale 23,000 15.05 346,058
2025-07-10 Burnett Patrick (See Remarks) Option Ex 23,000 .00 0
2025-07-01 Welgus Howard G. Sale 9,208 13.84 127,429
2025-06-18 Welgus Howard G. Sale 10,139 13.37 135,578
2025-06-13 Heron Patrick J Buy 2,646 13.08 34,609
2025-06-05 Heron Patrick J Buy 378 13.41 5,069
2025-06-04 Heron Patrick J Buy 1,890 13.32 25,176
2025-05-28 Matsuda Masaru (See Remarks) Sale 1,800 13.78 24,805
2025-05-19 Edwards Larry Todd (See Remarks) Sale 7,451 14.07 104,850
2025-05-15 Heron Patrick J Buy 2,520 13.62 34,317
2025-05-09 Heron Patrick J Buy 6,300 13.60 85,692
2025-05-08 Burnett Patrick (See Remarks) Sale 3,871 13.59 52,622
2025-05-02 Watanabe Todd Franklin (See Remarks) Sale 11,448 15.19 173,918
2025-05-02 Matsuda Masaru (See Remarks) Sale 5,030 15.20 76,456
2025-05-02 Burnett Patrick (See Remarks) Sale 2,597 15.19 39,443
2025-04-02 Topper David Joseph (Chief Financial Officer) Sale 9,600 15.80 151,699
2025-04-01 Welgus Howard G. Sale 10,000 15.12 151,240
2025-03-25 Watanabe Todd Franklin (See Remarks) Sale 2,171 17.56 38,131
2025-03-24 Watanabe Todd Franklin (See Remarks) Sale 1,500 17.52 26,281
2025-03-17 Watanabe Todd Franklin (See Remarks) Sale 1,200 17.61 21,136
2025-03-14 Burnett Patrick (See Remarks) Sale 12,242 15.04 184,107
2025-03-14 Burnett Patrick (See Remarks) Option Ex 12,242 .00 0
2025-03-13 Burnett Patrick (See Remarks) Sale 49,161 15.03 739,086
2025-03-13 Burnett Patrick (See Remarks) Option Ex 5,008 .00 0
2025-03-03 Welgus Howard G. Sale 10,000 13.01 130,050
2025-03-03 Matsuda Masaru (See Remarks) Sale 3,263 13.03 42,520
2025-02-03 Edwards Larry Todd (See Remarks) Sale 2,173 12.70 27,597
2025-02-03 Watanabe Todd Franklin (See Remarks) Sale 19,301 12.70 245,122
2025-02-03 Welgus Howard G. Sale 10,000 12.71 127,100
2025-02-03 Matsuda Masaru (See Remarks) Sale 8,338 12.70 105,892
2025-02-03 Burnett Patrick (See Remarks) Sale 12,116 12.70 153,873
2024-12-31 Burnett Patrick (See Remarks) Sale 1,691 14.00 23,674
2024-11-30 Edwards Larry Todd (See Remarks) Buy 1,093 7.11 7,766
2024-11-30 Matsuda Masaru (See Remarks) Buy 1,657 7.11 11,774
2024-11-22 Burnett Patrick (See Remarks) Sale 16,023 10.14 162,521
2024-11-22 Burnett Patrick (See Remarks) Option Ex 16,023 .00 0
2024-11-19 Matsuda Masaru (See Remarks) Sale 1,775 9.69 17,190
2024-11-15 Burnett Patrick (See Remarks) Sale 100 10.03 1,002
2024-11-15 Burnett Patrick (See Remarks) Option Ex 100 .00 0
2024-11-14 Burnett Patrick (See Remarks) Sale 69,126 10.29 711,652
2024-11-14 Burnett Patrick (See Remarks) Option Ex 18,377 .00 0
2024-11-11 Curran Terrie (Director) Sale 8,687 10.85 94,236
2024-11-04 Watanabe Todd Franklin (See Remarks) Sale 13,871 8.68 120,455
2024-11-04 Matsuda Masaru (See Remarks) Sale 5,015 8.68 43,550
2024-11-04 Burnett Patrick (See Remarks) Sale 15,441 8.68 134,089
2024-11-01 Welgus Howard G. Sale 10,000 8.65 86,540
2024-10-02 Edwards Larry Todd (SVP Chief Commercial Officer) Sale 3,725 10.01 37,294
2024-10-01 Welgus Howard G. Sale 10,000 9.26 92,620
2024-09-24 Topper David Joseph (Chief Financial Officer) Sale 11,626 9.48 110,260
2024-09-03 Welgus Howard G. Sale 10,000 10.77 107,700
2024-08-19 Burnett Patrick (See Remarks) Sale 1,728 8.29 14,318
2024-08-02 Watanabe Todd Franklin (See Remarks) Sale 14,487 9.02 130,643
2024-08-02 Matsuda Masaru (See Remarks) Sale 5,220 9.02 47,063
2024-08-02 Burnett Patrick (See Remarks) Sale 13,206 9.02 119,104
2024-08-01 Welgus Howard G. Sale 10,000 9.87 98,699
2024-08-01 Welgus Howard G. Option Ex 6,614 1.68 11,118
2024-07-01 Welgus Howard G. Sale 10,000 9.31 93,140
2024-07-01 Welgus Howard G. Option Ex 10,000 1.68 16,810
2024-06-04 Welgus Howard G. Sale 10,000 8.01 80,070
2024-06-04 Welgus Howard G. Option Ex 10,000 1.68 16,810
2024-05-31 Matsuda Masaru (See Remarks) Buy 4,000 1.69 6,768
2024-05-30 Burnett Patrick (See Remarks) Sale 23,000 8.75 201,319
2024-05-30 Burnett Patrick (See Remarks) Option Ex 23,000 .00 0
2024-05-29 Burnett Patrick (See Remarks) Sale 49,952 8.72 435,381
2024-05-28 Matsuda Masaru (See Remark) Sale 1,775 9.01 15,987
2024-05-17 Edwards Larry Todd (SVP Chief Commercial Officer) Sale 7,640 8.98 68,584
2024-05-02 Moore Matthew Richard (SVP and Chief Business Officer) Sale 4,681 8.74 40,902
2024-05-02 Watanabe Todd Franklin (See Remarks) Sale 13,783 8.74 120,435
2024-05-02 Matsuda Masaru (See Remark) Sale 5,016 8.74 43,829
2024-05-02 Burnett Patrick (See Remarks) Sale 9,555 8.74 83,491
2024-03-04 Heron Patrick J Buy 21,052 9.50 199,994
2024-01-02 Burnett Patrick (See Remarks) Sale 1,325 3.54 4,691
2023-12-01 Watanabe Todd Franklin (See Remarks) Option Ex 59,525 1.68 100,061
2023-11-21 Matsuda Masaru (See Remark) Sale 1,850 1.98 3,661
2023-10-24 Heron Patrick J (Director) Buy 80,000 2.50 200,000
2023-08-21 Burnett Patrick (See Remarks) Sale 1,605 7.04 11,307
2023-05-31 Watanabe Todd Franklin (See Remarks) Buy 1,463 6.38 9,333
2023-05-31 Matsuda Masaru (See Remark) Sale 1,830 7.80 14,277
2023-04-17 Welgus Howard G. Sale 8,500 13.97 118,728
2023-04-17 Welgus Howard G. Option Ex 8,500 1.68 14,288
2023-04-06 Welgus Howard G. Sale 8,500 12.01 102,085
2023-04-06 Welgus Howard G. Option Ex 8,500 1.68 14,288
2023-03-06 Burrows Scott L (Chief Financial Officer) Sale 291 15.26 4,441
2023-03-06 Watanabe Todd Franklin (See Remarks) Sale 2,435 15.26 37,167
2023-03-06 Lock Kenneth A. (Chief Commercial Officer) Sale 831 15.26 12,684
2023-03-06 Turney Patricia A. (SVP, Operations) Sale 831 15.26 12,684
2023-03-06 Burnett Patrick (See Remarks) Sale 851 15.26 12,988
2023-03-06 Osborne David W (Chief Technical Officer) Sale 690 15.26 10,531
2023-03-02 Burrows Scott L (Chief Financial Officer) Sale 1,434 16.17 23,186
2023-03-02 Moore Matthew Richard (See Remarks) Sale 1,610 16.17 26,032
2023-03-02 Watanabe Todd Franklin (See Remarks) Sale 5,472 16.17 88,476
2023-03-02 Lock Kenneth A. (Chief Commercial Officer) Sale 1,432 16.17 23,154
2023-03-02 Turney Patricia A. (SVP, Operations) Sale 1,432 16.17 23,154
2023-03-02 Matsuda Masaru (See Remarks) Sale 1,434 16.17 23,186
2023-03-02 Burnett Patrick (See Remarks) Sale 1,751 16.17 28,311
2023-03-02 Osborne David W (Chief Technical Officer) Sale 1,213 16.17 19,612
2023-02-28 Burrows Scott L (Chief Financial Officer) Sale 416 16.17 6,725
2023-02-28 Watanabe Todd Franklin (See Remarks) Sale 2,343 16.17 37,876
2023-02-28 Lock Kenneth A. (Chief Commercial Officer) Sale 936 16.17 15,131
2023-02-28 Turney Patricia A. (SVP, Operations) Sale 936 16.17 15,131
2023-02-28 Osborne David W (Chief Technical Officer) Sale 792 16.17 12,803
2023-02-15 Welgus Howard G. Sale 8,500 16.98 144,355
2023-02-15 Welgus Howard G. Option Ex 8,500 1.68 14,288
2023-02-14 Watanabe Todd Franklin (See Remarks) Sale 517 17.02 8,801
2023-02-13 Watanabe Todd Franklin (See Remarks) Sale 483 17.00 8,213
2023-02-01 Watanabe Todd Franklin (See Remarks) Sale 1,000 17.00 17,002
2023-01-17 Welgus Howard G. Sale 8,500 13.72 116,654
2023-01-17 Welgus Howard G. Option Ex 8,500 1.68 14,280
2022-11-21 Matsuda Masaru (See Remark) Sale 1,720 18.19 31,288
2022-11-15 Welgus Howard G. Sale 6,806 20.01 136,208
2022-11-15 Welgus Howard G. Option Ex 2,040 1.68 3,426
2022-10-07 Watanabe Todd Franklin (President and CEO) Sale 1,000 19.51 19,510
2022-09-16 Burrows Scott L (Chief Financial Officer) Option Ex 5,000 1.68 8,405
2022-08-15 Welgus Howard G. Sale 6,000 24.80 148,788
2022-07-18 Welgus Howard G. Sale 6,000 24.40 146,376
2022-07-08 Watanabe Todd Franklin (President and CEO) Sale 13,500 25.28 341,226
2022-07-08 Watanabe Todd Franklin (President and CEO) Option Ex 7,087 1.68 11,913
2022-07-08 Osborne David W (Chief Technical Officer) Sale 2,197 25.41 55,834
2022-07-06 Watanabe Todd Franklin (President and CEO) Sale 1,000 22.07 22,070
2022-06-24 Orbimed Capital Gp Vii Llc Sale 341,971 21.31 7,287,402
2022-06-06 Watanabe Todd Franklin (President and CEO) Sale 1,000 21.06 21,064
2022-06-02 Matsuda Masaru (SVP and General Counsel) Sale 1,795 19.73 35,418
2022-06-01 Welgus Howard G. Sale 2,500 20.61 51,537
2022-06-01 Welgus Howard G. Option Ex 2,500 1.68 4,202
2022-05-05 Watanabe Todd Franklin (President and CEO) Sale 1,000 21.76 21,760
2022-05-02 Welgus Howard G. Sale 2,500 20.45 51,112
2022-05-02 Welgus Howard G. Option Ex 2,500 1.13 2,824
2022-04-21 Osborne David W (Chief Technical Officer) Sale 2,197 20.42 44,871
2022-04-08 Orbimed Capital Gp Vii Llc Sale 200,000 20.71 4,142,000
2022-04-07 Orbimed Capital Gp Vii Llc Sale 344,996 20.66 7,127,617
2022-04-06 Orbimed Capital Gp Vii Llc Sale 333,204 20.69 6,893,990
2022-04-05 Watanabe Todd Franklin (President and CEO) Sale 1,000 21.43 21,430
2022-04-01 Welgus Howard G. Sale 7,500 20.02 150,187
2022-04-01 Welgus Howard G. Option Ex 7,500 .58 4,350
2022-03-09 Watanabe Todd Franklin (President and CEO) Sale 300 17.00 5,100
2022-03-07 Burrows Scott L (Chief Financial Officer) Sale 10 16.45 164
2022-03-07 Watanabe Todd Franklin (President and CEO) Sale 770 16.77 12,916
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ARQT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arcutis Biotherapeutics, Inc. (symbol ARQT, CIK number 1787306) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.